American College of Surgeons Recognizes Fox Chase Cancer Center as a Surgical Quality Partner

ACS
(From left) Sanjay Reddy, MD, FACS, Division Chief, Surgical Oncology; Stephanie Greco, MD, FACS, Director, Surgical Quality; and Jeffrey Farma, MD, FACS, Chair, Department of Surgery at Fox Chase Cancer Center.

Fox Chase Cancer Center was recently recognized by the American College of Surgeons (ACS) as a Surgical Quality Partner through participation in the organization’s Commission on Cancer and National Surgical Quality Improvement Program (NSQIP). 

The ACS NSQIP is a data registry designed to improve hospital-wide quality across all surgical departments. It helps teams make informed decisions about the improvement of quality of care while reducing complications and costs. 

“We are gratified to have been recognized as an ACS Surgical Quality Partner. We have a long-standing history of participation in numerous quality programs through the ACS and are committed to providing the highest quality surgical care for our patients,” said Stephanie Greco, MD, FACS, Director of Surgical Quality and Assistant Professor in the Department of Surgery at Fox Chase. 

“With this designation we hope to demonstrate our dedication to such programs and our drive to provide the best surgical experience and outcomes for our cancer community,” she added. 

“ACS quality programs are grounded in more than a century of experience, and participation is an important measure of a hospital’s surgical quality,” said ACS Executive Director & CEO Patricia L. Turner, MD, MBA, FACS. “As an ACS Surgical Quality Partner, Fox Chase Cancer Center has shown a commitment to providing the best possible patient care, evaluating that care in a rigorous fashion, and dedicating themselves to continuous self-improvement.” 

Surgical Quality Partners recognized by the ACS have effectively demonstrated their dedication to providing surgeons with the tools and resources necessary to make quality a top priority. Recognition as a Surgical Quality Partner assures patients that they can expect the highest quality care driven by data, expert input, and proven processes. 

Fox Chase emphasizes offering varied and supportive training environments as well as being part of the rich scientific and biotech environment in the Philadelphia region. The Center works to foster an environment conducive to strong collaboration across all disciplines, from basic to translational research to top-notch clinical care. 

Fox Chase has previously been recognized for high performance across numerous metrics in NSQIP, including being named a Meritorious Performing Hospital. This honor means that the surgical quality at Fox Chase ranked among the top 100 participating ACS NSQIP hospitals in the nation. 

ACS is an organization dedicated to improving the care of surgical patients and safeguarding standards of care. The organization helps to improve patient care by addressing three critical components: care, evaluation, and improvement. The ACS accreditation and verification programs, products, guidelines, and tools improve quality in trauma, cancer, breast disease, bariatrics, children’s, geriatrics, and overall surgical care.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427